ReviewNPJ vaccines2026
Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework.
Hong Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewNPJ vaccines2026
Hong Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.